13F-HR filed by Alphabet Inc.
Alphabet Inc. filed this 13F-HR for the quarter ended 2025-06-30, filed 2025-08-01, with 36 holding rows worth $2,135,229,735.
- Accession
- 0001652044-25-000063
- Filer
- CIK 1652044
- Filed
- 2025-08-01
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2025
A holdings report, 39 entries on the cover page, a total value of $2,135,229,735 stated on the cover page (in dollars after the unit check, H1), rows summing to $2,135,229,735 with VALUE read as dollars as filed, 13F file number 028-22702. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerGV Management Company, L.L.C.028-22704
- included managerGoogle LLC028-22705
- included managerCapitalG II LP028-22706
- included managerVerily Life Sciences LLC028-22703
- included managerCapitalG III LP028-23659
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| AST SPACEMOBILE INC COM CL A | 00217D100 | Stock | 8,943,486 | $417,929,101 | dollars as filed | |
| ARM HOLDINGS PLC | 042068205 | SPONSORED ADS | 1,960,784 | $317,137,204 | dollars as filed | |
| FRESHWORKS INC CLASS A COM | 358054104 | Stock | 16,206,643 | $241,641,047 | dollars as filed | |
| PLANET LABS PBC | 72703X106 | COM CL A | 31,942,641 | $194,850,110 | dollars as filed | |
| REVOLUTION MEDICINES INC COM | 76155X100 | Stock | 4,133,277 | $152,063,261 | dollars as filed | |
| METSERA INC | 59267L107 | COM | 4,961,744 | $141,161,617 | dollars as filed | |
| VERVE THERAPEUTICS INC | 92539P101 | COM | 12,168,489 | $136,652,131 | dollars as filed | |
| GITLAB INC CLASS A COM | 37637K108 | Stock | 2,724,712 | $122,911,758 | dollars as filed | |
| TEMPUS AI INC CL A | 88023B103 | Stock | 1,551,102 | $98,557,021 | dollars as filed | |
| DEXCOM INC COM | 252131107 | Stock | 1,036,937 | $90,514,231 | dollars as filed | |
| UIPATH INC | 90364P105 | CL A | 7,034,337 | $90,039,514 | dollars as filed | |
| PRIME MEDICINE INC | 74168J101 | COM | 15,062,498 | $37,204,370 | dollars as filed | |
| MAZE THERAPEUTICS INC COM | 578784100 | Stock | 2,412,471 | $29,601,019 | dollars as filed | |
| OSCAR HEALTH INC | 687793109 | CL A | 481,988 | $10,333,823 | dollars as filed | |
| SANA BIOTECHNOLOGY INC | 799566104 | COM | 2,812,500 | $7,678,125 | dollars as filed | |
| MONTE ROSA THERAPEUTICS INC | 61225M102 | COM | 1,464,015 | $6,602,708 | dollars as filed | |
| VERA THERAPEUTICS INC | 92337R101 | COMMON STOCK | 241,264 | $5,684,180 | dollars as filed | |
| BEAM THERAPEUTICS INC | 07373V105 | COM | 321,604 | $5,470,484 | dollars as filed | |
| RELAY THERAPEUTICS INC COM | 75943R102 | Stock | 1,568,753 | $5,427,886 | dollars as filed | |
| DIANTHUS THERAPEUTICS INC | 252828108 | COM | 208,697 | $3,888,025 | dollars as filed | |
| LYELL IMMUNOPHARMA INC COM NEW | 55083R203 | Stock | 293,256 | $2,592,383 | dollars as filed | |
| SPERO THERAPEUTICS INC | 84833T103 | COM | 889,979 | $2,580,939 | dollars as filed | |
| FOGHORN THERAPEUTICS INC | 344174107 | COMMON STOCK | 500,901 | $2,354,235 | dollars as filed | |
| GENEDX HOLDINGS CORP | 81663L200 | COM CL A | 22,711 | $2,096,452 | dollars as filed | |
| AUTOLUS THERAPEUTICS PLC SPON | 05280R100 | COM | 698,262 | $1,592,037 | dollars as filed | |
| Tscan Therapeutics Inc | 89854M101 | COM | 1,077,080 | $1,561,766 | dollars as filed | |
| TAYSHA GENE THERAPIES INC | 877619106 | COMMON STOCK | 640,882 | $1,480,437 | dollars as filed | |
| BARINTHUS BIOTHERAPEUTICS PL | 91864C107 | ADS | 1,513,644 | $1,407,689 | dollars as filed | |
| EXACT SCIENCES CORP COM | 30063P105 | Stock | 23,205 | $1,233,114 | dollars as filed | |
| FRACTYL HEALTH INC | 35168W103 | COM | 662,584 | $1,073,386 | dollars as filed | |
| HYPERFINE INC | 44916K106 | Common Stock | 898,720 | $647,078 | dollars as filed | |
| TENAYA THERAPEUTICS INC | 87990A106 | COM | 915,705 | $558,580 | dollars as filed | |
| CORTEXYME INC | 22053A107 | COM | 189,122 | $312,051 | dollars as filed | |
| ALECTOR INC | 014442107 | COMMON STOCK | 175,866 | $246,212 | dollars as filed | |
| FULCRUM THERAPEUTICS INC | 359616109 | COMMON STOCK | 14,262 | $98,123 | dollars as filed | |
| REPLIGEN CORP COM | 759916109 | Stock | 383 | $47,638 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001652044-25-000063 | this filing | 2025-08-01 | acceptance time not in the bulk data set |